WhiteOak Capital Pharma and Healthcare Fund Regular Growth
WhiteOak Capital Pharma and Healthcare Fund Regular Growth: NAV ₹17.48, AUM ₹825 Cr, expense ratio 2.69%. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.
Key facts
- NAV
- ₹17.4820 (19 Nov 2026)
- 1-year return
- 24.07%
- Fund size (AUM)
- ₹825 Cr
- Expense ratio
- 2.69%
- Exit load
- Nil
- Minimum investment
- Minimum of Rs. 500/- and in multiples of Re. 1/-
- Category
- Sectoral Fund
- Benchmark
- BSE Healthcare TRI
- Riskometer
- Very High Risk
- Fund manager
- FM1 - Mr. Ramesh Mantri; FM2- Mr. Piyush Baranwal; FM3 - Mr. Dheeresh Pathak ; FM4 - Mr. Ashish Agrawal; FM5 - Ms. Trupti Agrawal
- Launch date
- 16 Jan 2024
Frequently asked questions
What is the NAV of WhiteOak Capital Pharma and Healthcare Fund Regular Growth today?
The NAV of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹17.4820 as of 19 Nov 2026.
What are the returns of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
24.07% over 1 year. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
The expense ratio (TER) is 2.69% a year. This Regular plan includes a distributor commission; the Direct plan of the same fund costs less.
What is the AUM (fund size) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
WhiteOak Capital Pharma and Healthcare Fund Regular Growth manages ₹825 Cr.
Is there an exit load on WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
Exit load: Nil.
How risky is WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
Its SEBI riskometer is "Very High Risk" and it is in the Sectoral Fund category.
What is the benchmark of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?
The benchmark is BSE Healthcare TRI. This page compares the fund with its benchmark's total-return index (TRI).
Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.